Drug treatment strategies for secondary lymphedema
Secondary lymphedema is a chronic disease caused by lymphatic system dysfunction, which affects about 140 to 250 million people worldwide and has the second highest incidence among disabling diseases. With the advancement of malignant tumor treatment technology and the acceleration of the aging proc...
Saved in:
| Main Authors: | Fu Yongda, Duan Man, Pu Luya, Du Jianshi |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Office of International Journal of Geriatrics
2025-07-01
|
| Series: | Guoji laonian yixue zazhi |
| Subjects: | |
| Online Access: | http://gwll.publish.founderss.cn/thesisDetails#10.3969/j.issn.1674-7593.2025.04.001&lang=en |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Upper limb lymphedema treatment application
by: Geraldo Magela Salomé, et al.
Published: (2023-10-01) -
Reprogramming lymphatic endothelial glucose metabolism for the treatment of lymphangiogenesis-related disease
by: Ziran Zhang, et al.
Published: (2025-08-01) -
Inhibition of Th2 Differentiation Accelerates Chronic Wound Healing by Facilitating Lymphangiogenesis
by: Bracha L. Pollack, et al.
Published: (2025-04-01) -
Predictors of the Efficacy of Lymphedema Decongestive Therapy
by: Andrej Dzupina, et al.
Published: (2025-01-01) -
Lymphedema after combination treatment of head and neck tumors
by: A. M. Stepanova, et al.
Published: (2018-07-01)